Fracture Risk Linked to Proton Pump Inhibitors Versus <scp>H2</scp> Receptor Antagonists in Autoimmune Rheumatic and Gastrointestinal Disease Patients
The study demonstrates that patients diagnosed with autoimmune rheumatic and gastrointestinal diseases who were aged 65+ face increased fracture risks when using PPIs, particularly when there is a simultaneous intake of glucocorticoids.
Authors
- Yung‐Heng Lee
- Wei‐Min Chu (ORCID: https://orcid.org/0000-0001-9870-8362)
- Miaoyu Zeng
- Shiow‐Ing Wang (ORCID: https://orcid.org/0000-0003-3407-9020)
- Frank Buttgereit (ORCID: https://orcid.org/0000-0003-2534-550X)
- Andriko Palmowski (ORCID: https://orcid.org/0000-0002-3456-0597)
Institutions
- National Sun Yat-sen University (TW)
- Minghsin University of Science and Technology (TW)
- National Yang Ming Chiao Tung University (TW)
- National Chung Hsing University (TW)
- Frederiksberg Hospital (DK)
- Taichung Veterans General Hospital (TW)
- Chung Shan Medical University Hospital (TW)
- Ministry of Health and Welfare (TW)
- Taichung Hospital (TW)
- Shu-Te University (TW)
- Charité - Universitätsmedizin Berlin (DE)
- Chung Shan Medical University (TW)
Publication Details
- Journal
- International Journal of Rheumatic Diseases
- Published
- 2025-02-01
- DOI
- https://doi.org/10.1111/1756-185x.70055
- Citations
- 2
- Primary Topic
- Gastroesophageal reflux and treatments
- Type
- article
- Field-Weighted Citation Impact
- 3.62
Funders
- Chung Shan Medical University Hospital